Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
Description
About Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
The Dependoparvovirus primate1 Capsid protein VP1 Peptide (IEDB: 45886) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Capsid protein Peptide, H-NSLANPGIA-OH (Uniprot: P03135 aa: 517-525) from JPT is produced under strict quality control and quality management.
Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA - Specifications
- Peptide sequence: H-NSLANPGIA-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
References:
Read References with JPT’s Antigen Peptides
Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA has been described in:
Identification of mouse AAV capsid-specific CD8+ T cell epitopes., Mol Ther, 2005 (PMID: 16263332)
Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets., Hum Gene Ther, 2007 (PMID: 17324107)
Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells., Eur J Immunol, 2006 (PMID: 16479539)
Documentation
Documentation for Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
Properties
Properties of Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Dependoparvovirus primate1 |
Protein Name: | Capsid protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Dependoparvovirus primate1 Capsid protein VP1 517-525, NSLANPGIA
Information | Values |
---|---|
Sequence: | H-NSLANPGIA-OH |
Specifications: | 9mer peptide as TFA salt |